What are the potential interactions between Cephalexin and Keppra (Levetiracetam) in a patient with a history of seizures or epilepsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin and Keppra (Levetiracetam) Interaction

Direct Answer

There is no clinically significant pharmacokinetic or pharmacodynamic interaction between cephalexin and levetiracetam (Keppra), and they can be safely co-administered without dose adjustments. 1

Key Clinical Considerations

No Drug-Drug Interaction

  • Levetiracetam lacks cytochrome P450 enzyme-inducing potential and is not associated with clinically significant pharmacokinetic interactions with other drugs, including antibiotics. 2
  • The European guidelines specifically recommend non-enzyme-inducing anticonvulsants like levetiracetam to avoid impacting metabolism of other medications including antibiotics. 1
  • Continue levetiracetam at the current dose without adjustment when starting cephalexin, as no dose modifications are required. 1

Important Caveats About Cephalosporins and Seizures

While cephalexin and levetiracetam don't interact pharmacologically, cephalosporins themselves can lower the seizure threshold and potentially trigger seizures, particularly in high-risk situations. 3

Risk factors for cephalosporin-induced seizures include:

  • Damage to the blood-brain barrier (cerebral trauma, encephalitis)
  • High antibiotic doses
  • Renal failure without adequate dose adjustment
  • Pre-existing seizure disorders 3

Critical Monitoring Point

If the patient develops altered consciousness during cephalosporin therapy, perform an EEG to rule out nonconvulsive status epilepticus, which is a particularly dangerous and difficult-to-diagnose complication of cephalosporin treatment. 3

Clinical Management Algorithm

  1. Prescribe both medications without dose adjustments - no interaction exists between them 1

  2. Ensure cephalexin dosing is appropriate for renal function - this prevents accumulation that could lower seizure threshold 3

  3. Monitor for seizure control as usual - do not attribute breakthrough seizures to drug interaction 1

  4. If breakthrough seizures occur, investigate:

    • Underlying infection or fever (the actual seizure trigger) 1
    • Sleep deprivation 1
    • Medication non-compliance 1
    • Cephalexin accumulation in renal impairment 3
  5. Verify levetiracetam compliance - non-compliance is a more common cause of breakthrough seizures than drug interactions 1

Common Pitfalls to Avoid

  • Do not discontinue or reduce levetiracetam when starting cephalexin - this is unnecessary and may precipitate withdrawal seizures 1
  • Do not assume drug interaction if seizures occur - investigate the infection, fever, or other precipitating factors first 1
  • Do not use high-dose cephalosporins without renal dose adjustment in patients with kidney disease, as this increases seizure risk 3

Levetiracetam's Favorable Profile

Levetiracetam is particularly suitable for patients requiring antibiotics because:

  • Minimal drug interactions across all medication classes 2
  • No effect on antibiotic metabolism 1
  • Rapid and complete absorption unaffected by other medications 2
  • Primarily renal elimination without hepatic metabolism 2

References

Guideline

Safe Use of Azithromycin with Levetiracetam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[The risk of epileptic seizures during antibiotic therapy].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.